Hypofibrinogenemia Due to L-Asparaginase: Studies of Fibrinogen Survival Using Autologous 131I-Fibrinogen
Richard E. Bettigole, E. S. HIMELSTEIN, Herbert Friedrich Oettgen, George O. Clifford
Abstract
Open-access reader
Richard E. Bettigole, E. S. HIMELSTEIN, Herbert Friedrich Oettgen, George O. Clifford
Abstract
Open-access reader
Abstract Plasma fibrinogen levels fall, often dramatically, in patients receiving L-asparaginase. Studies of six patients using autologous 131I-fibrinogen showed that at a dose of 1000 I.U./kg./day L-asparaginase had no effect on their rates of fibrinogen disappearance. The fall in their plasma fibrinogen levels, therefore, must have been a result of decreased synthesis since it could not be ascribed to increased utilization or destruction of fibrinogen.
OpenAlex reports 62 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Abstract Plasma fibrinogen levels fall, often dramatically, in patients receiving L-asparaginase. Studies of six patients using autologous 131I-fibrinogen showed that at a dose of 1000 I.U./kg./day L-asparaginase had no effect on their rates of fibrinogen disappearance. The fall in their plasma fibrinogen levels, therefore, must have been a result of decreased synthesis since it could not be ascribed to increased utilization or destruction of fibrinogen.
Key concepts: Hypofibrinogenemia, Fibrinogen, Medicine, Internal medicine, Afibrinogenemia, Endocrinology, Immunology